BIOMAT Database Logo BIOMAT Database Logo

Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. 2007

Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Australian Animal Health Laboratory, CSIRO Livestock Industries, PO Bag 24, Geelong, Victoria, 3220 Australia. deborah.middleton@csiro.au

The current Asian H5N1 highly pathogenic avian influenza virus has spread over much of Asia and into Europe and Africa. As well as affecting village and commercial chicken operations in many South East Asian countries, it differs from past H5 avian influenza viruses in that it causes morbidity and mortalities in other domesticated birds, such as ducks and turkeys and in wild water birds. Effective vaccines that can prevent infection, as well as disease, and be used in a variety of avian species are needed for field use. In this report, a bivalent H5N9+H7N1 oil emulsion vaccine is compared, in ducks, to a monovalent H5N3 oil emulsion vaccine that has been derived by reverse genetics with an H5 from A/chicken/Vietnam/C58/04. While both vaccines protected against morbidity, the monovalent vaccine provided effective protection, with no evidence of shedding of the challenge virus and no serological response to the H5N1 challenge virus.

UI MeSH Term Description Entries
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008297 Male Males
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D004372 Ducks A water bird in the order Anseriformes (subfamily Anatinae (true ducks)) with a broad blunt bill, short legs, webbed feet, and a waddling gait. Duck
D005260 Female Females
D005585 Influenza in Birds Infection of domestic and wild fowl and other BIRDS with INFLUENZA A VIRUS. Avian influenza usually does not sicken birds, but can be highly pathogenic and fatal in domestic POULTRY. Avian Flu,Avian Influenza,Fowl Plague,Influenza, Avian,Avian Influenzas,Flu, Avian,Influenza in Bird,Influenzas, Avian,Plague, Fowl
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D015164 Vaccines, Inactivated Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. Inactivated Vaccine,Killed Vaccine,Killed Vaccines,Vaccines, Killed,Inactivated Vaccines,Vaccine, Inactivated,Vaccine, Killed
D017201 Virus Shedding The expelling of virus particles from the body. Important routes include the respiratory tract, genital tract (important in INFECTIOUS DISEASE TRANSMISSION, VERTICAL), and intestinal tract. Viral Shedding,Shedding, Viral,Shedding, Virus

Related Publications

Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam.
March 2010, Avian diseases,
Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
January 2016, PloS one,
Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Protective efficacy of an inactivated vaccine against H9N2 avian influenza virus in ducks.
September 2015, Virology journal,
Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Avian influenza vaccines against H5N1 'bird flu'.
March 2014, Trends in biotechnology,
Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza.
January 2001, Avian diseases,
Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge.
March 2007, Avian diseases,
Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks.
May 2024, Vaccine,
Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Adenovirus-based vaccines against avian-origin H5N1 influenza viruses.
February 2015, Microbes and infection,
Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Suboptimal protection against H5N1 highly pathogenic avian influenza viruses from Vietnam in ducks vaccinated with commercial poultry vaccines.
October 2013, Vaccine,
Deborah Middleton, and John Bingham, and Paul Selleck, and Sue Lowther, and Laurie Gleeson, and Philip Lehrbach, and Simon Robinson, and Jeff Rodenberg, and Mahesh Kumar, and Marion Andrew
Efficacy of two H5N9-inactivated vaccines against challenge with a recent H5N1 highly pathogenic avian influenza isolate from a chicken in Thailand.
March 2007, Avian diseases,
Copied contents to your clipboard!